These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 23160008)
1. Prevention of amyloid-β fibril formation using antibodies against the C-terminal region of amyloid-β1-40 and amyloid-β1-42. Montañés M; Casabona D; Sarasa L; Pesini P; Sarasa M J Alzheimers Dis; 2013; 34(1):133-7. PubMed ID: 23160008 [TBL] [Abstract][Full Text] [Related]
2. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro. Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038 [TBL] [Abstract][Full Text] [Related]
3. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ Hojati S; Ghahghaei A; Lagzian M J Biomol Struct Dyn; 2018 Jun; 36(8):2118-2130. PubMed ID: 28633568 [TBL] [Abstract][Full Text] [Related]
4. Critical role of interfaces and agitation on the nucleation of Abeta amyloid fibrils at low concentrations of Abeta monomers. Morinaga A; Hasegawa K; Nomura R; Ookoshi T; Ozawa D; Goto Y; Yamada M; Naiki H Biochim Biophys Acta; 2010 Apr; 1804(4):986-95. PubMed ID: 20100601 [TBL] [Abstract][Full Text] [Related]
5. Nuclear magnetic resonance evidence for the dimer formation of beta amyloid peptide 1-42 in 1,1,1,3,3,3-hexafluoro-2-propanol. Shigemitsu Y; Iwaya N; Goda N; Matsuzaki M; Tenno T; Narita A; Hoshi M; Hiroaki H Anal Biochem; 2016 Apr; 498():59-67. PubMed ID: 26772162 [TBL] [Abstract][Full Text] [Related]
6. Direct evidence for self-propagation of different amyloid-β fibril conformations. Spirig T; Ovchinnikova O; Vagt T; Glockshuber R Neurodegener Dis; 2014; 14(3):151-9. PubMed ID: 25300967 [TBL] [Abstract][Full Text] [Related]
7. Effect of different anti-Abeta antibodies on Abeta fibrillogenesis as assessed by atomic force microscopy. Legleiter J; Czilli DL; Gitter B; DeMattos RB; Holtzman DM; Kowalewski T J Mol Biol; 2004 Jan; 335(4):997-1006. PubMed ID: 14698294 [TBL] [Abstract][Full Text] [Related]
8. In vitro antiaggregation and deaggregation potential of Rhizophora mucronata and its bioactive compound (+)- catechin against Alzheimer's beta amyloid peptide (25-35). Suganthy N; Sheeja Malar D; Pandima Devi K Neurol Res; 2016 Dec; 38(12):1041-1051. PubMed ID: 27766923 [TBL] [Abstract][Full Text] [Related]
9. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro. Hao J; Zhang W; Zhang P; Liu R; Liu L; Lei G; Su C; Miao J; Li Z Neuropeptides; 2010 Aug; 44(4):305-13. PubMed ID: 20363024 [TBL] [Abstract][Full Text] [Related]
10. Dissecting the behaviour of β-amyloid peptide variants during oligomerization and fibrillation. Shi JM; Zhang L; Liu EQ J Pept Sci; 2017 Nov; 23(11):810-817. PubMed ID: 28795459 [TBL] [Abstract][Full Text] [Related]
11. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain. Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814 [TBL] [Abstract][Full Text] [Related]
12. The Properties of Amyloid-β Fibrils Are Determined by their Path of Formation. Brännström K; Islam T; Gharibyan AL; Iakovleva I; Nilsson L; Lee CC; Sandblad L; Pamrén A; Olofsson A J Mol Biol; 2018 Jun; 430(13):1940-1949. PubMed ID: 29751013 [TBL] [Abstract][Full Text] [Related]
13. Dissection of the key steps of amyloid-β peptide 1-40 fibrillogenesis. Leite JP; Gimeno A; Taboada P; Jiménez-Barbero JJ; Gales L Int J Biol Macromol; 2020 Dec; 164():2240-2246. PubMed ID: 32771514 [TBL] [Abstract][Full Text] [Related]
14. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration. Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689 [TBL] [Abstract][Full Text] [Related]
15. The effect of terminal groups and halogenation of KLVFF peptide on its activity as an inhibitor of β-amyloid aggregation. Khalili Samani E; Mofid MR; Malakoutikhah M J Pept Sci; 2020 Feb; 26(2):e3227. PubMed ID: 31845472 [TBL] [Abstract][Full Text] [Related]
16. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity. Singh PK; Maji SK Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against large oval aggregates of Aβ1-42. Shimizu T; Yoshimune K; Komoriya T; Akiyama T; Ye X; Kohno H J Biosci Bioeng; 2013 Feb; 115(2):216-20. PubMed ID: 23041139 [TBL] [Abstract][Full Text] [Related]
19. Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by Aβ(1-40) and Aβ(1-42). Lindberg DJ; Wranne MS; Gilbert Gatty M; Westerlund F; Esbjörner EK Biochem Biophys Res Commun; 2015 Mar; 458(2):418-23. PubMed ID: 25660454 [TBL] [Abstract][Full Text] [Related]
20. Secondary structure and interfacial aggregation of amyloid-beta(1-40) on sodium dodecyl sulfate micelles. Rangachari V; Reed DK; Moore BD; Rosenberry TL Biochemistry; 2006 Jul; 45(28):8639-48. PubMed ID: 16834338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]